Patents by Inventor Danielle E. KELLAR

Danielle E. KELLAR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260049114
    Abstract: The invention relates to proteins for use in the prevention, treatment or amelioration of kidney diseases or kidney damage, more particularly where the protein is a follistatin-fusion protein.
    Type: Application
    Filed: June 14, 2023
    Publication date: February 19, 2026
    Inventors: Lara Kevorkian, Timothy Scott Johnson, Breda Twomey, Janine Powers, Danielle E. Kellar
  • Patent number: 11975046
    Abstract: The present invention relates to methods for the treatment of fibrosis. The invention discloses new research which demonstrates that interferon-lambda has directly acting anti-fibrotic effects both in vitro and in vivo and may be used to provide effective new therapies for the treatment of multiple types of fibrosis.
    Type: Grant
    Filed: June 29, 2023
    Date of Patent: May 7, 2024
    Assignees: UCB BIOPHARMA SRL, FIVE PRIME THERAPEUTICS, INC.
    Inventors: Timothy Scott Johnson, Breda Twomey, Janine Powers, Danielle E. Kellar
  • Publication number: 20240000893
    Abstract: The present invention relates to methods for the treatment of fibrosis. The invention discloses new research which demonstrates that interferon-lambda has directly acting anti-fibrotic effects both in vitro and in vivo and may be used to provide effective new therapies for the treatment of multiple types of fibrosis.
    Type: Application
    Filed: June 29, 2023
    Publication date: January 4, 2024
    Applicants: UCB BIOPHARMA SRL, FIVE PRIME THERAPEUTICS, INC.
    Inventors: Timothy Scott JOHNSON, Breda TWOMEY, Janine POWERS, Danielle E. KELLAR